• 14 days; • 28 days with recovery period – GLP compliant.
General Recommendations and Objectives
• Repeated dose toxicity studies should be carried out in two mammal species (one non-rodent);
Duration of repeated dose toxicity studies depends on the duration of the proposed therapeutic use in humans; • The route of administration should be the same as intended for humans.
